Fair Value Calculator Fair Value Calculator
EN DE

HISARSP (HISARSP) Fair Value & Analysis

IN · Market cap ₹171M

H HISARSP HISARSP · BSE
Price₹45.89
Fair Value₹122.68
Upside+167.3%
Quality60/100
Watch HISARSP for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹78.55 – ₹176.95

Fair value as of: Jul 5, 2026

From 23 valuation models · updated today

Share price −10.5% over the past month.

Price vs Fair Value (12 months)

₹67.13 ₹41.67 Fair Value ₹122.68 Jul 2025 Jul 2026

12‑month range ₹41.67 – ₹67.13 · fair‑value band ₹78.55 – ₹176.95 · the ₹45.89 price screens below the ₹122.68 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HISARSP (HISARSP) currently trades at ₹45.89, while our model-based Fair Value estimate is ₹122.68 — implying the stock looks roughly 167.3% undervalued today. We read business quality at 60/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, HISARSP generated revenue of ₹441M at a net margin of 7.5%. Revenue grew 0.8% year over year. It earns a return on equity of 12.3%. Net debt stands at ₹12.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹78.55 (bear case) to ₹176.95 (bull case); at ₹45.89, the current price sits below that range. The share trades about 32% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹441M
Revenue growth (YoY) +0.8%
Net margin 7.5%
Return on equity 12.3%
Free cash flow ₹20.4M FY2026
P/E ratio 5.2
More key figures
Operating margin 7.4%
EPS (TTM) ₹8.85
EPS growth (YoY) -36.0%
Net debt ₹12.1M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HISARSP reported revenue of ₹441M in FY2026 versus ₹345M in FY2022, a compound +6.4%/yr. Reported net income was ₹33.1M in FY2026, compounding −5.4%/yr from FY2022.

Revenue +6.4%/yr
FY22 ₹345M
FY23 ₹451M
FY24 ₹420M
FY25 ₹449M
FY26 ₹441M
Net income −5.4%/yr
FY22 ₹41.3M
FY23 ₹33.1M
FY24 ₹20.2M
FY25 ₹29.3M
FY26 ₹33.1M

Is HISARSP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "HISARSP Fair Value". https://www.fairvalue-calculator.com/stock/HISARSP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is HISARSP (HISARSP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹122.68 versus a price of ₹45.89 — about +167% (undervalued). Model-based estimate, not financial advice.
What is the fair value of HISARSP?
Our model-based fair value for HISARSP is ₹122.68 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹45.89.
What is the quality score of HISARSP?
HISARSP has a Quality Score of 60/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of HISARSP (HISARSP)?
HISARSP reported trailing-twelve-month revenue of about ₹441M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of HISARSP?
The net profit margin of HISARSP is about 7.5%, meaning it keeps roughly 7.5% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.